GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (FRA:L020) » Definitions » EV-to-Revenue

Britannia Life Sciences (FRA:L020) EV-to-Revenue : 2.70 (As of Jun. 01, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Britannia Life Sciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Britannia Life Sciences's enterprise value is €13.07 Mil. Britannia Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €4.84 Mil. Therefore, Britannia Life Sciences's EV-to-Revenue for today is 2.70.

The historical rank and industry rank for Britannia Life Sciences's EV-to-Revenue or its related term are showing as below:

FRA:L020' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.21   Med: 3.23   Max: 6.02
Current: 2.85

During the past 4 years, the highest EV-to-Revenue of Britannia Life Sciences was 6.02. The lowest was 2.21. And the median was 3.23.

FRA:L020's EV-to-Revenue is ranked better than
72.22% of 997 companies
in the Biotechnology industry
Industry Median: 7.44 vs FRA:L020: 2.85

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-01), Britannia Life Sciences's stock price is €0.0235. Britannia Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.03. Therefore, Britannia Life Sciences's PS Ratio for today is 0.81.


Britannia Life Sciences EV-to-Revenue Historical Data

The historical data trend for Britannia Life Sciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Britannia Life Sciences EV-to-Revenue Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
- 5.27 3.94 2.85

Britannia Life Sciences Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 2.85 2.85 2.88 3.30

Competitive Comparison of Britannia Life Sciences's EV-to-Revenue

For the Biotechnology subindustry, Britannia Life Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Britannia Life Sciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Britannia Life Sciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Britannia Life Sciences's EV-to-Revenue falls into.


;
;

Britannia Life Sciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Britannia Life Sciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=13.071/4.84
=2.70

Britannia Life Sciences's current Enterprise Value is €13.07 Mil.
Britannia Life Sciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Britannia Life Sciences  (FRA:L020) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Britannia Life Sciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0235/0.029
=0.81

Britannia Life Sciences's share price for today is €0.0235.
Britannia Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Britannia Life Sciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Britannia Life Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Britannia Life Sciences Business Description

Traded in Other Exchanges
Address
120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally.

Britannia Life Sciences Headlines

No Headlines